IonPath has appointed Sander Gubbens as CEO. He replaces company cofounder Harris Fienberg.
Gubbens was most recently president of Gatan, a cryo-electron microscopy firm, which was acquired by Amtek in 2019 for $925 million. He has over 30 years of experience in developing and commercializing technology in the life science, materials science, and semiconductor industries. Prior to Gatan, he held senior R&D roles at KLA-Tencor.
An inventor on 17 patents and a member of the board of PCR instrument maker Combinati, Gubbens holds a doctorate in applied physics from The Netherlands' Delft University of Technology and an MBA from the University of California, Berkeley Hass School of Business.